{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T02:05:19Z","timestamp":1774404319848,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T00:00:00Z","timestamp":1332460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The prevalence of type II diabetes among individuals suffering from schizophrenia or schizoaffective disorders is more than double that of the general population. By 2005, North American professional medical associations of Psychiatry, Diabetes, and Endocrinology responded by recommending continuous metabolic monitoring for this population to control complications from obesity and diabetes. However, these recommendations do not identify the types of effective treatment for people with schizophrenia who have type II diabetes. To fill this gap, this systematic evidence review identifies effective lifestyle interventions that enhance quality care in individuals who are suffering from type II diabetes and schizophrenia or other schizoaffective disorders.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A systematic search from Medline, CINAHL, PsycINFO, and ISI Web of Science was conducted. Of the 1810 unique papers that were retrieved, four met the inclusion\/exclusion criteria and were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The results indicate that diabetes education is effective when it incorporates diet and exercise components, while using a design that addresses challenges such as cognition, motivation, and weight gain that may result from antipsychotics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This paper begins to point to effective interventions that will improve type II diabetes management for people with schizophrenia or other schizoaffective disorders.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-244x-12-24","type":"journal-article","created":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T05:49:57Z","timestamp":1332568197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Effective lifestyle interventions to improve type II diabetes self-management for those with schizophrenia or schizoaffective disorder: a systematic review"],"prefix":"10.1186","volume":"12","author":[{"given":"Adriana","family":"Cimo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erene","family":"Stergiopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiachen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Bonato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn S","family":"Dewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,23]]},"reference":[{"key":"966_CR1","unstructured":"World Health Organization: Diabetes Fact sheet N\u00b0312. [http:\/\/www.who.int\/mediacentre\/factsheets\/fs312\/en\/]"},{"key":"966_CR2","unstructured":"World Health Organization: 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. [http:\/\/www.who.int\/nmh\/Actionplan-PC-NCD-2008.pdf]"},{"key":"966_CR3","volume-title":"Nutrition Therapy and Pathophysiology","author":"M Nelms","year":"2010","unstructured":"Nelms M, Sucher KP, Lacey K, Long Roth S: Nutrition Therapy and Pathophysiology. 2010, Belmont, CA: Wadsworth Cengage Learning, 2","edition":"2"},{"key":"966_CR4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2337\/diacare.27.2.596","volume":"27","author":"American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity","year":"2004","unstructured":"American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity: Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004, 27: 596-601.","journal-title":"Diabetes Care"},{"key":"966_CR5","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/S0924-9338(10)71700-4","volume":"25","author":"A Heald","year":"2010","unstructured":"Heald A: Physical health in schizophrenia: a challenge for antipsychotic therapy. Eur Psychiatry. 2010, 25: S6-S11.","journal-title":"Eur Psychiatry"},{"key":"966_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.apnu.2006.10.004","volume":"21","author":"P El-Mallakh","year":"2007","unstructured":"El-Mallakh P: Doing my best: Poverty and self-care among individuals with schizophrenia and diabetes mellitus. Arch Psychiatr Nurs. 2007, 21: 49-60. 10.1016\/j.apnu.2006.10.004.","journal-title":"Arch Psychiatr Nurs"},{"key":"966_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/0269881105058380","volume":"19","author":"SCL Gough","year":"2005","unstructured":"Gough SCL, O'Donovan MC: Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?. J Psychopharmacol. 2005, 19: 47-55. 10.1177\/0269881105058380.","journal-title":"J Psychopharmacol"},{"key":"966_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.clinthera.2005.02.017","volume":"27","author":"A Krosnick","year":"2005","unstructured":"Krosnick A, Wilson MG: A retrospective chart review of the clinical effects of atypical antipsychotic drugs on glycemic control in institutionalized patients with schizophrenia and comorbid diabetes mellitus. Clin Ther. 2005, 27: 320-326. 10.1016\/j.clinthera.2005.02.017.","journal-title":"Clin Ther"},{"key":"966_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2165\/00003495-200464070-00003","volume":"64","author":"K Melkersson","year":"2004","unstructured":"Melkersson K, Dahl ML: Adverse metabolic effects associated with atypical antipsychotics - Literature review and clinical implications. Drugs. 2004, 64: 701-723. 10.2165\/00003495-200464070-00003.","journal-title":"Drugs"},{"key":"966_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/0269881107075509","volume":"21","author":"AH Barnett","year":"2007","unstructured":"Barnett AH, Mackin P, Chaudhry I, Farooqi A, Gadsby R, Heald A, Hill J, Millar H, Peveler R, Rees A, et al: Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia. J Psychopharmacol. 2007, 21: 357-373.","journal-title":"J Psychopharmacol"},{"key":"966_CR11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/070674370605100804","volume":"51","author":"TA Cohn","year":"2006","unstructured":"Cohn TA, Sernyak MJ: Metabolic monitoring for patients treated with antipsychotic medications. Can J Psychiatry-Revue Canadienne De Psychiatrie. 2006, 51: 492-501.","journal-title":"Can J Psychiatry-Revue Canadienne De Psychiatrie"},{"key":"966_CR12","first-page":"111","volume":"29","author":"V Woo","year":"2005","unstructured":"Woo V, Harris SB, Houlden RL: Canadian Diabetes Association Position Paper: Antipsychotic Medications and Associated Risks of Weight Gain and Diabetes. Can J Diabetes. 2005, 29: 111-112.","journal-title":"Can J Diabetes"},{"issue":"Supplement 1","key":"966_CR13","first-page":"S1","volume":"32","author":"Canadian Diabetes Association","year":"2008","unstructured":"Canadian Diabetes Association: Clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Journal of Diabetes. 2008, 32 (Supplement 1): S1-S201.","journal-title":"Canadian Journal of Diabetes"},{"issue":"Sup","key":"966_CR14","first-page":"S11","volume":"35","author":"American Diabetes Association","year":"2012","unstructured":"American Diabetes Association: Standards of medical care in diabetes - 2012. Diabetes Care. 2012, 35 (Sup): S11-S63.","journal-title":"Diabetes Care"},{"key":"966_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1176\/ps.2007.58.4.536","volume":"58","author":"RW Goldberg","year":"2007","unstructured":"Goldberg RW, Kreyenbuhl JA, Medoff DR, Dickerson FB, Wohlheiter K, Fang J, Brown CH, Dixon LB: Quality of diabetes care among adults with serious mental illness. Psychiatr Serv. 2007, 58: 536-543. 10.1176\/appi.ps.58.4.536.","journal-title":"Psychiatr Serv"},{"key":"966_CR16","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1001\/archinte.165.22.2631","volume":"165","author":"SM Frayne","year":"2005","unstructured":"Frayne SM, Halanych JH, Miller DR, Wang F, Lin H, Pogach L, Sharkansky EJ, Keane TM, Skinner KM, Rosen CS, Berlowitz DR: Disparities in Diabetes Care. Arch Intern Med. 2005, 165: 2631-2638. 10.1001\/archinte.165.22.2631.","journal-title":"Arch Intern Med"},{"key":"966_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1176\/appi.psy.46.5.418","volume":"46","author":"FB Dickerson","year":"2005","unstructured":"Dickerson FB, Goldberg RW, Brown CH, Kreyenbuhl JA, Wohlheiter K, Fang L, Medoff D, Dixon LB: Diabetes knowledge among persons with serious mental illness and type 2 diabetes. Psychosomatics. 2005, 46: 418-424. 10.1176\/appi.psy.46.5.418.","journal-title":"Psychosomatics"},{"key":"966_CR18","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2337\/dc10-1139","volume":"34","author":"T Becker","year":"2011","unstructured":"Becker T, Hux J: Risk of acute complications of diabetes among people with schizophrenia in Ontario, Canada. Diabetes Care. 2011, 34: 398-402. 10.2337\/dc10-1139.","journal-title":"Diabetes Care"},{"key":"966_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/070674379103600401","volume":"36","author":"SC Newman","year":"1991","unstructured":"Newman SC, Bland RC: Mortality in a cohort of patients with schizophrenia: a record linkage study. Can j psychiatry Revue canadienne de psychiatrie. 1991, 36: 239-245.","journal-title":"Can j psychiatry Revue canadienne de psychiatrie"},{"key":"966_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10926-009-9224-x","volume":"20","author":"SE Lagerveld","year":"2010","unstructured":"Lagerveld SE, Bultmann U, Franche RL, van Dijk FJ, Vlasveld MC, van der Feltz-Cornelis CM, Bruinvels DJ, Huijs JJ, Blonk RW, van der Klink JJ, Nieuwenhuijsen K: Factors associated with work participation and work functioning in depressed workers: a systematic review. J Occup Rehabil. 2010, 20: 275-292. 10.1007\/s10926-009-9224-x.","journal-title":"J Occup Rehabil"},{"key":"966_CR21","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jclinepi.2005.12.010","volume":"59","author":"C Mallen","year":"2006","unstructured":"Mallen C, Peat G, Croft P: Quality assessment of observational studies is not commonplace in systematic reviews. J Clin Epidemiol. 2006, 59: 765-769. 10.1016\/j.jclinepi.2005.12.010.","journal-title":"J Clin Epidemiol"},{"key":"966_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1176\/appi.psy.49.2.123","volume":"49","author":"D Dickinson","year":"2008","unstructured":"Dickinson D, Gold JM, Dickerson FB, Medoff D, Dixon LB: Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes. Psychosomatics. 2008, 49: 123-131. 10.1176\/appi.psy.49.2.123.","journal-title":"Psychosomatics"},{"key":"966_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.schres.2006.05.010","volume":"86","author":"CL McKibbin","year":"2006","unstructured":"McKibbin CL, Patterson TL, Norman G, Patrick K, Jin H, Roesch S, Mudaliar S, Barrio C, O'Hanlon K, Griver K, et al: A lifestyle intervention for older schizophrenia patients with diabetes mellitus: A randomized controlled trial. Schizophr Res. 2006, 86: 36-44. 10.1016\/j.schres.2006.05.010.","journal-title":"Schizophr Res"},{"key":"966_CR24","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.4088\/JCP.08m04740yel","volume":"70","author":"JP Lindenmayer","year":"2009","unstructured":"Lindenmayer JP, Khan A, Wance D, Maccabee N, Kaushik S: Outcome Evaluation of a Structured Educational Wellness Program in Patients With Severe Mental Illness. J Clin Psychiatry. 2009, 70: 1385-1396. 10.4088\/JCP.08m04740yel.","journal-title":"J Clin Psychiatry"},{"key":"966_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2975\/34.4.2011.324.327","volume":"34","author":"A Teachout","year":"2011","unstructured":"Teachout A, Kaiser SM, Wilkniss SM, Moore H: Paxton House: Integrating Mental Health and Diabetes Care for People with Serious Mental Illnesses in a Residential Setting. Psychiatric Rehabil J. 2011, 34: 324-327. 10.2975\/34.4.2011.324.327.","journal-title":"Psychiatric Rehabil J"},{"key":"966_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.schres.2009.09.039","volume":"121","author":"CL McKibbin","year":"2010","unstructured":"McKibbin CL, Golshan S, Griver K, Kitchen K, Wykes TL: A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: A 6-month follow-up analysis. Schizophr Res. 2010, 121: 203-206. 10.1016\/j.schres.2009.09.039.","journal-title":"Schizophr Res"},{"key":"966_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2190\/8J17-J4PB-F2KX-05YY","volume":"33","author":"V Lerner","year":"2003","unstructured":"Lerner V, Libov I, Kanevsky M: High-dose olanzapine-induced improvement of preexisting type 2 diabetes mellitus in schizophrenic patients. Int J Psychiatry Med. 2003, 33: 403-410. 10.2190\/8J17-J4PB-F2KX-05YY.","journal-title":"Int J Psychiatry Med"},{"key":"966_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1440-1819.2006.01469.x","volume":"60","author":"P-L Wu","year":"2006","unstructured":"Wu P-L, Lane H-Y, Su K-P: Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus. Psychiatry Clin Neurosci. 2006, 60: 115-116. 10.1111\/j.1440-1819.2006.01469.x.","journal-title":"Psychiatry Clin Neurosci"},{"key":"966_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1176\/appi.psy.43.1.67","volume":"43","author":"K Melkersson","year":"2002","unstructured":"Melkersson K, Hulting A-L: Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine. Psychosomatics: J Consult Liaison Psychiatry. 2002, 43: 67-70. 10.1176\/appi.psy.43.1.67.","journal-title":"Psychosomatics: J Consult Liaison Psychiatry"},{"key":"966_CR30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1177\/070674370204700721","volume":"47","author":"JC Waldman","year":"2002","unstructured":"Waldman JC, Yaren S: Atypical antipsychotics and glycemia: a case report. The Can J Psychiatry\/La Revue canadienne de psychiatrie. 2002, 47: 686-687.","journal-title":"The Can J Psychiatry\/La Revue canadienne de psychiatrie"},{"key":"966_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/0269881104040253","volume":"18","author":"S Ashim","year":"2004","unstructured":"Ashim S, Warrington S, Anderson IM: Management of diabetes mellitus occurring during treatment with olanzapine: report of six cases and clinical implications. J Psychopharmacol. 2004, 18: 128-132. 10.1177\/0269881104040253.","journal-title":"J Psychopharmacol"},{"key":"966_CR32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3109\/08039488.2010.500397","volume":"64","author":"D Gothefors","year":"2010","unstructured":"Gothefors D, Adolfsson R, Attvall S, Erlinge D, Jarbin H, Lindstrom K, von Hausswolff-Juhlin YL, Morgell R, Toft E, Osby U: Swedish clinical guidelines-Prevention and management of metabolic risk in patients with severe psychiatric disorders. Nordic J Psychiatry. 2010, 64: 294-302. 10.3109\/08039488.2010.500397.","journal-title":"Nordic J Psychiatry"},{"key":"966_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1741-7015-6-17","volume":"6","author":"R Ganguli","year":"2008","unstructured":"Ganguli R, Brar JS, Mahmoud R, Berry SA, Pandina GJ: Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded study. Bmc Med. 2008, 6: 17-10.1186\/1741-7015-6-17.","journal-title":"Bmc Med"},{"key":"966_CR34","first-page":"27","volume":"Spec No","author":"PJ Weiden","year":"2006","unstructured":"Weiden PJ: Switching in the era of atypical antipsychotics. An updated review. Postgrad Med. 2006, Spec No: 27-44.","journal-title":"Postgrad Med"},{"key":"966_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/schbul\/19.2.287","volume":"19","author":"JM Kane","year":"1993","unstructured":"Kane JM, Marder SR: Psychopharmacologic treatment of schizophrenia. Schizophr Bull. 1993, 19: 287-302.","journal-title":"Schizophr Bull"},{"key":"966_CR36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4088\/JCP.v65n0404","volume":"65","author":"M Menza","year":"2004","unstructured":"Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M: Managing Atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry. 2004, 65: 471-477.","journal-title":"J Clin Psychiatry"},{"key":"966_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2337\/diacare.27.1.155","volume":"27","author":"JS Torgerson","year":"2004","unstructured":"Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L: XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004, 27: 155-161. 10.2337\/diacare.27.1.155.","journal-title":"Diabetes Care"},{"key":"966_CR38","volume-title":"Diabetologia","author":"EL Lim","year":"2011","unstructured":"Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R: Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011,"},{"issue":"Suppl 8","key":"966_CR39","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1055\/s-2006-956282","volume":"131","author":"R Landgraf","year":"2006","unstructured":"Landgraf R: HbA1c-the gold standard in the assessment of diabetes treatment?. Dtsch Med Wochenschr. 2006, 131 (Suppl 8): S243-246.","journal-title":"Dtsch Med Wochenschr"},{"key":"966_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5271\/sjweh.504","volume":"26","author":"GA Ariens","year":"2000","unstructured":"Ariens GA, van Mechelen W, Bongers PM, Bouter LM, van der Wal G: Physical risk factors for neck pain. Scand J Work Environ Health. 2000, 26: 7-19. 10.5271\/sjweh.504.","journal-title":"Scand J Work Environ Health"},{"key":"966_CR41","unstructured":"American Diabetes Association: Diabetes Statistics. [http:\/\/www.diabetes.org\/diabetes-%20basics\/diabetes-statistics\/]"},{"key":"966_CR42","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(07)60361-4","volume":"369","author":"LL Lipscombe","year":"2007","unstructured":"Lipscombe LL, Hux JE: Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet. 2007, 369: 750-756. 10.1016\/S0140-6736(07)60361-4.","journal-title":"Lancet"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-12-24\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:49:18Z","timestamp":1630522158000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-12-24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,23]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-12-24","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,23]]},"assertion":[{"value":"12 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"24"}}